Insider filing · CTY
Robert Nelsen
Director
profile →
City Therapeutics, Inc.
CTY · Healthcare · 2 filings in 24 months
ticker →
Robert Nelsen bought $3.1M of City Therapeutics (CTY)
Executed Oct 19, disclosed Oct 19, the same day.
Value, as filed
$3.1M
170,000 sh × $18.00
Executed
Oct 19
the trade date, as filed
Disclosed
Oct 19
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
RNRobert Nelsen (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in City Therapeutics, Inc. (CTY). The largest single filing was $3.1M of CTY (170,000 sh × $18.00, as filed), executed Oct 19. The median gap between execution and disclosure was 0 days.
The name
CTYHealthcare · City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineerin…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→